Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarketing Adverse Experience Reporting
Published Date: 1/17/2025
Notice
Summary
The FDA is updating how drug companies report problems people have after using their medicines. This helps keep medicines safe by making sure the FDA gets clear, timely info. Drug makers need to follow new rules and send comments by February 18, 2025, but there’s no big cost change expected.
Analyzed Economic Effects
6 provisions identified: 0 benefits, 6 costs, 0 mixed.
Mandatory Electronic Adverse Event Reports
If you manufacture, pack, distribute, or sponsor drugs or biologics, all adverse experience reports and followup reports must be submitted to FDA in electronic format (via the Electronic Submissions Gateway or the Safety Reporting Portal). Waivers of the electronic requirement may be granted for good cause.
Large Estimated Increase in Paperwork Burden
FDA reports the total burden hours for this information collection have increased by 61,614,921 hours and 2,546,112 responses compared to the previous renewal; current total estimated annual reporting hours are 51,690,702 and recordkeeping hours are 24,627,827.8. FDA also estimates operating and maintenance costs of approximately $25,000 (reporting) and $22,000 (recordkeeping) annually.
Long Recordkeeping Timeframes Required
Manufacturers, applicants, packers, and distributors must keep records of adverse drug experience reports for long periods: 10 years for prescription drug applicants and manufacturers (21 CFR 314.80(j) and 310.305(g)) and 6 years for nonprescription (OTC) drug adverse event records under section 760(e).
15-Day Alerts and Periodic Reporting Deadlines
Applicants must send 15-day 'Alert' reports for serious, unexpected adverse drug experiences (Sec. 314.80(c)(1)(i)) and must submit periodic safety reports quarterly for the first 3 years after U.S. approval and annually thereafter (Sec. 314.80(c)(2) and 600.80(c)(2)).
OTC Products Included in Reporting Rules
Over-the-counter (OTC) drug products marketed without an approved application — including products under the OTC Drug Monograph Review process or marketed outside the monograph system — are required to submit adverse event reports in electronic format under section 760 and related regulations (Sec. 329.100).
5-Day Notice Rule for Combination Products
For combination products that include a drug, if an event involves death, serious injury, or an adverse event and the product sponsor receives the information, the sponsor must provide that information to the other constituent part applicant(s) no later than 5 calendar days after receipt (21 CFR 4.103).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-17203, Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Update Its Fees Schedule in Connection With Binary Options That Overlie the Mini-S&P 500 Index
Cboe Exchange is updating its fees for binary options tied to the Mini-S&P 500 Index, called XSP binary options. They’re adding standard transaction fees and removing these options from some special fee programs. These changes took effect right away on August 12, 2026, and will impact traders using these specific options.
2026-17241, Foreign-Trade Zone (FTZ) 183, Notification of Proposed Production Activity; Ichor Systems, Inc.; (Semiconductor Equipment); Austin, Texas
2026-17208, Information Collection Being Submitted for Review and Approval to Office of Management and Budget
As part of its continuing effort to reduce paperwork burdens, as required by the Paperwork Reduction Act (PRA) of 1995, the Federal Communications Commission (FCC or the Commission) invites the general public and other Federal Agencies to take this opportunity to comment on the following information collection. Pursuant to the Small Business Paperwork Relief Act of 2002, the FCC seeks specific comment on how it might further reduce the information collection burden for small business concerns with fewer than 25 employees. The Commission may not conduct or sponsor a collection of information unless it displays a currently valid Office of Management and Budget (OMB) control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the PRA that does not display a valid OMB control number.
2026-17236, Proposed Collection; Comment Request
In compliance with the Paperwork Reduction Act of 1995, the OUSD(P&R) announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; the accuracy of the agency's estimate of the burden of the proposed information collection; ways to enhance the quality, utility, and clarity of the information to be collected; and ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.
2026-17252, National Environmental Policy Act Implementing Procedures: Forest and Woodland Density Management Categorical Exclusion
This notice announces a revision to the Department of the Interior (Department)'s National Environmental Policy Act (NEPA) procedures by adding a new categorical exclusion (CE) for forest and woodland density management in the Department's Handbook of NEPA Implementing Procedures, Appendix 2: Bureau Categorical Exclusions.
2026-17248, Pacific Fishery Management Council; Public Meetings
The Pacific Fishery Management Council is holding public meetings from September 16-21, 2026, in Vancouver, Washington, and online. These meetings affect fishermen, environmental groups, and coastal communities by discussing fishery rules, budgets, and habitat protection. You can join live, comment remotely, and stay updated on important fishery decisions that might impact fishing seasons and local economies.
Previous / Next Documents
Previous: 2025-01150, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Maternal and Child Health Jurisdictional Survey Instrument for the Title V MCH Block Grant Program
HRSA is asking for public feedback on a survey tool used by states to report how they’re helping moms and kids stay healthy through the Title V MCH Block Grant program. This update aims to keep the survey clear and useful, making sure states can track their progress well. Comments are open until February 18, 2025, and this process helps keep the program effective without adding extra costs.
Next: 2025-01152, Agency Information Collection Activities; Proposed Collection; Improving the Quality and Representativeness of the Treatment Center Program Data-Data Modifications to the Current Survey Instrument Format to Minimize Misclassification; Withdrawal of Notice
The FDA has decided to cancel a planned update to how they collect data from treatment centers, which was meant to reduce mistakes in surveys. This change affects treatment centers and anyone involved in reporting data, but now there won’t be any new forms or costs. The cancellation was announced on January 17, 2025, so no changes will happen anytime soon.